Soken Chemical & Engineering Co., Ltd. (TYO:4972)
2,959.00
-35.00 (-1.17%)
At close: Feb 6, 2026
TYO:4972 Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 6,187 | 8,413 | 7,576 | 7,013 | 7,203 | 6,100 |
Short-Term Investments | 9,500 | 7,500 | 5,500 | 3,000 | 4,000 | 3,500 |
Cash & Short-Term Investments | 15,687 | 15,913 | 13,076 | 10,013 | 11,203 | 9,600 |
Cash Growth | 8.66% | 21.70% | 30.59% | -10.62% | 16.70% | 42.33% |
Receivables | 11,794 | 11,343 | 11,678 | 10,810 | 10,425 | 10,748 |
Inventory | 5,684 | 5,784 | 5,313 | 5,872 | 5,656 | 4,029 |
Other Current Assets | 390 | 395 | 255 | 593 | 589 | 223 |
Total Current Assets | 33,555 | 33,435 | 30,322 | 27,288 | 27,873 | 24,600 |
Property, Plant & Equipment | 17,582 | 18,883 | 18,793 | 18,540 | 16,135 | 13,952 |
Long-Term Investments | 169 | 159 | 82 | 94 | 236 | 520 |
Other Intangible Assets | 780 | 669 | 328 | 273 | 328 | 386 |
Long-Term Deferred Tax Assets | 935 | 967 | 1,056 | 1,077 | 1,008 | 943 |
Other Long-Term Assets | - | 1 | 1 | 3 | 2 | 2 |
Total Assets | 53,021 | 54,114 | 50,582 | 47,275 | 45,582 | 40,403 |
Accounts Payable | 7,956 | 7,337 | 8,082 | 7,576 | 8,886 | 6,189 |
Accrued Expenses | 572 | 722 | 749 | 599 | 717 | 756 |
Short-Term Debt | 1,336 | 1,551 | 1,093 | 1,223 | 1,092 | 943 |
Current Portion of Long-Term Debt | 645 | 912 | 806 | 1,641 | 90 | 120 |
Current Income Taxes Payable | 344 | 271 | 431 | 352 | 328 | 699 |
Other Current Liabilities | 1,807 | 2,502 | 2,745 | 2,285 | 1,796 | 3,287 |
Total Current Liabilities | 12,660 | 13,295 | 13,906 | 13,676 | 12,909 | 11,994 |
Long-Term Debt | 1,335 | 1,671 | 2,366 | 1,670 | 2,440 | 1,000 |
Pension & Post-Retirement Benefits | 974 | 1,008 | 1,479 | 1,772 | 1,802 | 1,793 |
Other Long-Term Liabilities | 137 | 138 | 97 | 181 | 84 | 26 |
Total Liabilities | 15,106 | 16,112 | 17,848 | 17,299 | 17,235 | 14,813 |
Common Stock | 3,361 | 3,361 | 3,361 | 3,361 | 3,361 | 3,361 |
Additional Paid-In Capital | 3,449 | 3,435 | 3,422 | 3,412 | 3,402 | 3,391 |
Retained Earnings | 27,089 | 26,034 | 22,442 | 20,515 | 19,697 | 18,272 |
Treasury Stock | -2 | -12 | -22 | -40 | -58 | -76 |
Comprehensive Income & Other | 4,018 | 5,184 | 3,531 | 2,728 | 1,945 | 642 |
Total Common Equity | 37,915 | 38,002 | 32,734 | 29,976 | 28,347 | 25,590 |
Shareholders' Equity | 37,915 | 38,002 | 32,734 | 29,976 | 28,347 | 25,590 |
Total Liabilities & Equity | 53,021 | 54,114 | 50,582 | 47,275 | 45,582 | 40,403 |
Total Debt | 3,316 | 4,134 | 4,265 | 4,534 | 3,622 | 2,063 |
Net Cash (Debt) | 12,371 | 11,779 | 8,811 | 5,479 | 7,581 | 7,537 |
Net Cash Growth | 31.06% | 33.68% | 60.81% | -27.73% | 0.58% | 72.59% |
Net Cash Per Share | 746.05 | 710.69 | 532.32 | 331.62 | 459.73 | 457.95 |
Filing Date Shares Outstanding | 16.6 | 16.58 | 16.56 | 16.53 | 16.5 | 16.47 |
Total Common Shares Outstanding | 16.6 | 16.58 | 16.56 | 16.53 | 16.5 | 16.47 |
Working Capital | 20,895 | 20,140 | 16,416 | 13,612 | 14,964 | 12,606 |
Book Value Per Share | 2284.69 | 2292.04 | 1976.31 | 1813.09 | 1717.76 | 1553.55 |
Tangible Book Value | 37,135 | 37,333 | 32,406 | 29,703 | 28,019 | 25,204 |
Tangible Book Value Per Share | 2237.69 | 2251.69 | 1956.51 | 1796.58 | 1697.88 | 1530.11 |
Order Backlog | - | 4,738 | 2,876 | 3,223 | 2,625 | 3,569 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.